Published in Neurology on April 09, 2002
Dementia, butterfly ballots, and voter competence. Neurology (2002) 0.75
Do persons with dementia vote? Neurology (2002) 0.75
Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD. N Engl J Med (1992) 5.42
A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer. N Engl J Med (1990) 4.66
Is the defensive use of diagnostic tests good for patients, or bad? Med Decis Making (1998) 4.17
Cost-effectiveness analysis in a setting of budget constraints--is it equitable? N Engl J Med (1996) 4.13
Direct sale of sildenafil (Viagra) to consumers over the Internet. N Engl J Med (1999) 3.42
Prescription drug use and self-prescription among resident physicians. JAMA (1998) 3.20
Phylogenetic analysis and evolution of RNase P RNA in proteobacteria. J Bacteriol (1991) 2.71
Phylogenetic comparative analysis and the secondary structure of ribonuclease P RNA--a review. Gene (1989) 2.45
The ability of persons with Alzheimer disease (AD) to make a decision about taking an AD treatment. Neurology (2005) 2.27
Phylogenetic comparative analysis of RNA secondary structure. Methods Enzymol (1989) 2.18
Patient-reported impotence and incontinence after nerve-sparing radical prostatectomy. J Natl Cancer Inst (1997) 2.07
Chemotherapy with or without radiation therapy in limited small-cell carcinoma of the lung. N Engl J Med (1987) 2.05
Cognitive processes and the decisions of some parents to forego pertussis vaccination for their children. J Clin Epidemiol (1996) 2.04
A pilot clinical trial of oral pentosan polysulfate and oral hydroxyzine in patients with interstitial cystitis. J Urol (2003) 1.93
A national study of ethics committees. Am J Bioeth (2001) 1.90
Classifying general medicine readmissions. Are they preventable? Veterans Affairs Cooperative Studies in Health Services Group on Primary Care and Hospital Readmissions. J Gen Intern Med (1996) 1.89
Are supplementary services provided during methadone maintenance really cost-effective? Am J Psychiatry (1997) 1.81
Physician characteristics associated with decisions to withdraw life support. Am J Public Health (1995) 1.76
Barriers to office-based screening sigmoidoscopy: does reimbursement cover costs? Ann Intern Med (1999) 1.74
Long-term follow-up of a phase III intergroup study of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study. J Clin Oncol (1997) 1.70
Substantial variation in the acceptance of medically complex live kidney donors across US renal transplant centers. Am J Transplant (2008) 1.57
A randomized trial of anticoagulation with warfarin and of alternating chemotherapy in extensive small-cell lung cancer by the Cancer and Leukemia Group B. J Clin Oncol (1989) 1.56
Biases in how physicians choose to withdraw life support. Lancet (1993) 1.52
Predicting non-elective hospital readmissions: a multi-site study. Department of Veterans Affairs Cooperative Study Group on Primary Care and Readmissions. J Clin Epidemiol (2000) 1.48
Health and health care among housestaff in four U.S. internal medicine residency programs. J Gen Intern Med (2000) 1.46
Prenatal screening for toxoplasmosis. Obstet Gynecol (1997) 1.41
Residency reform: opportunity knocks. J Gen Intern Med (1991) 1.40
The illusion of deterministic rules. Ann Intern Med (1997) 1.39
The HIT Expert Probability (HEP) Score: a novel pre-test probability model for heparin-induced thrombocytopenia based on broad expert opinion. J Thromb Haemost (2010) 1.36
Discrepancies in pediatric bone mineral density reference data: potential for misdiagnosis of osteopenia. J Pediatr (1999) 1.26
Expression of cell cycle-regulated proteins in prostate cancer. Cancer Res (1996) 1.23
Timing payments to subjects of mail surveys: cost-effectiveness and bias. J Clin Epidemiol (1995) 1.20
Cursing the darkness: are there limits to end-of-life research? J Gen Intern Med (1998) 1.19
A phase I study of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator gene to a lung segment of individuals with cystic fibrosis. Hum Gene Ther (1999) 1.16
Patient-reported symptoms after primary therapy for early prostate cancer: results of a prospective cohort study. J Clin Oncol (1998) 1.16
Measuring patient expectations: does the instrument affect satisfaction or expectations? Med Care (2001) 1.14
Treatments used in women with interstitial cystitis: the interstitial cystitis data base (ICDB) study experience. The Interstitial Cystitis Data Base Study Group. Urology (2000) 1.13
Randomized multicenter clinical trial of myofascial physical therapy in women with interstitial cystitis/painful bladder syndrome and pelvic floor tenderness. J Urol (2012) 1.11
Do nonpatients underestimate the quality of life associated with chronic health conditions because of a focusing illusion? Med Decis Making (2001) 1.05
Primary care physicians' decisions to perform flexible sigmoidoscopy. J Gen Intern Med (1999) 1.05
Caregivers' preferences for the treatment of patients with Alzheimer's disease. Neurology (2000) 1.02
Inpatient rehabilitation after stroke: a comparison of lengths of stay and outcomes in the Veterans Affairs and non-Veterans Affairs health care system. Med Care (2001) 1.00
Complications after treatment with external-beam irradiation in early-stage prostate cancer patients: a prospective multiinstitutional outcomes study. J Clin Oncol (1997) 0.99
Changes in quality of life following treatment for early prostate cancer. Urology (1999) 0.99
Medical specialists prefer to withdraw familiar technologies when discontinuing life support. J Gen Intern Med (1995) 0.98
Obtaining informed consent for clinical pain research: patients' concerns and information needs. Pain (2001) 0.98
A new instrument for residency program evaluation. J Gen Intern Med (1997) 0.97
Physicians' perspectives on the uncertainties and implications of chromosomal microarray testing of children and families. Clin Genet (2012) 0.96
The public's attitudes toward incentives for organ donation. Transplant Proc (1999) 0.95
Transplantation of kidneys from donors at increased risk for blood-borne viral infection: recipient outcomes and patterns of organ use. Am J Transplant (2009) 0.94
Designing pain research from the patient's perspective: what trial end points are important to patients with chronic pain? Pain Med (2001) 0.94
Inclusion of the herpes simplex thymidine kinase gene in a replicating adenovirus does not augment antitumor efficacy. Gene Ther (2001) 0.93
Preference for equity as a framing effect. Med Decis Making (2001) 0.93
Public preferences for efficiency and racial equity in kidney transplant allocation decisions. Transplant Proc (1996) 0.92
Effects of Bowman-Birk inhibitor concentrate (BBIC) in patients with benign prostatic hyperplasia. Prostate (2001) 0.92
Risk screening in a medicare/medicaid population administrative data versus self report. J Gen Intern Med (2001) 0.91
Public preferences for prevention versus cure: what if an ounce of prevention is worth only an ounce of cure? Med Decis Making (1998) 0.91
The impact of skin damage due to cutaneous lupus on quality of life. Br J Dermatol (2014) 0.90
How preliminary data affect people's stated willingness to enter a hypothetical randomized controlled trial. J Investig Med (1997) 0.89
Measuring community benefits provided by for-profit and nonprofit hospitals. Health Aff (Millwood) (2001) 0.88
Are preferences for equity over efficiency in health care allocation "all or nothing"? Med Care (2000) 0.88
Cost-effectiveness of pharmacogenetic testing to tailor smoking-cessation treatment. Pharmacogenomics J (2008) 0.87
Structure and catalytic function in ribonuclease P. Cold Spring Harb Symp Quant Biol (1987) 0.87
Prospective evaluation of growth, nutritional status, and body composition in children with cystic fibrosis. Am J Clin Nutr (2000) 0.87
Systemic IFN-beta gene therapy results in long-term survival in mice with established colorectal liver metastases. J Clin Invest (2001) 0.86
Conceptual challenges in tailoring physician performance assessment to individual practice. Med Educ (2002) 0.83
Radiation-associated morbidity in patients undergoing small-field external beam irradiation for prostate cancer. Int J Radiat Oncol Biol Phys (1998) 0.82
What predicts gastroenterologists' and surgeons' diagnosis and management of common bile duct stones? Gastrointest Endosc (1997) 0.82
5-Fluorouracil and leucovorin therapy in patients with hormone refractory prostate cancer: an Eastern Cooperative Oncology Group phase II study (E1889). Am J Clin Oncol (1998) 0.81
Comfort level, financial incentives, and consent for organ donation. Transplant Proc (1998) 0.81
Carboplatin or iproplatin in advanced non-small cell lung cancer: a Cancer and Leukemia Group B Study. Cancer Treat Rep (1987) 0.81
Allocation of transplantable organs: do people want to punish patients for causing their illness? Liver Transpl (2001) 0.80
Single, sequential, and multiple alkylating agent therapy for multiple myeloma: a CALGB Study. J Clin Oncol (1986) 0.80
The presence of hospitalists in medical education. Acad Med (2000) 0.80
Alternating cycles of combination chemotherapy for patients with recurrent Hodgkin's disease following radiotherapy. A prospectively randomized study by the Cancer and Leukemia Group B. J Clin Oncol (1986) 0.80
Open label extension studies and the ethical design of clinical trials. IRB (2002) 0.80
Cost and effectiveness of hepatitis B immunization. Ann Intern Med (1993) 0.80
Phase II trial of etoposide and cis-diaminodichloro-platinum in patients with refractory and relapsed Hodgkin's disease: Cancer and Leukemia Group B (CALGB) Study 8353. Med Pediatr Oncol (1990) 0.79
Phase I/II trial of etoposide and carboplatin in extensive small-cell lung cancer. A report from the Cancer and Leukemia Group B. Am J Clin Oncol (1993) 0.79
A prospective study of body composition changes in children with cystic fibrosis. Ann N Y Acad Sci (2000) 0.78
Inhibition of oxidative phosphorylation by organotin thiocarbamates. Chem Biol Interact (1989) 0.78
Comparative impact on prostanoid biosynthesis of celecoxib and the novel nonsteroidal anti-inflammatory drug CG100649. Clin Pharmacol Ther (2012) 0.77
Optimising maternal-fetal outcomes in preterm labour: a decision analysis. Br J Obstet Gynaecol (1998) 0.77
Group sequential methods and sample size savings in biomarker-disease association studies. Genetics (2003) 0.76
Individual choice in spending accounts. Can we rely on employees to choose well? Med Care (1996) 0.76
Maternal behavior following rehabilitation of rats with intergenerational malnutrition. 2. Contribution of mothers and pups to deficits in lactation-related behaviors. J Nutr (1981) 0.76
Effect of radiologic stage III substage on nonsurgical therapy of non-small cell lung cancer. Cancer (1993) 0.76
A phase II trial of edatrexate in patients with advanced renal cell carcinoma. An Eastern Cooperative Oncology Group study. Am J Clin Oncol (1997) 0.75
Praxis less than perfect. Hastings Cent Rep (1995) 0.75
The role of employee flexible spending accounts in health care financing. Am J Public Health (1996) 0.75
Offensive testing--the balancing act, the evil twin, and the pure play. Med Decis Making (1998) 0.75
High-dose etoposide therapy for extensive small cell lung cancer: a Cancer and Leukemia Group B Study. Cancer Treat Rep (1987) 0.75
The pathologic and clinical heterogeneity of lymphocyte-depleted Hodgkin's disease. J Clin Oncol (1986) 0.75
Phase II trial of 4'-deoxydoxorubicin (DxDx) in non-small cell lung cancer: a Cancer and Leukemia Group B Trial. Med Pediatr Oncol (1988) 0.75
Further explorations of medical decisions for individuals and for groups. Med Decis Making (2000) 0.75
Colorectal cancer screening with sigmoidoscopy: primary care issues. LDI Issue Brief (1999) 0.75
Guidelines for reporting outcomes of lymphoma trials. J Clin Oncol (1988) 0.75
A phase II trial of cyclophosphamide, etoposide, and cisplatin with combined chest and brain radiotherapy in limited small-cell lung cancer: a Cancer and Leukemia Group B Study. J Clin Oncol (1987) 0.75
Phase II trial of etoposide and cisplatin for refractory small cell lung cancer: a Cancer and Leukemia Group B Study. Med Pediatr Oncol (1990) 0.75